This list is an analysis based on recent market events. It's not an investment recommendation.
About
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. It develops Ortho-R, a formulation for rotator cuff repair; Ortho-M, a biopolymer for meniscus repair; Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing, as well as ORTHO-T, a biopolymer formulation for tendon healing and regeneration. The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022. ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada.
The current price of CHNXF is $0.01 USD — it has increased by +586.36% in the past 24 hours. Watch ChitogenX stock price performance more closely on the chart.
What is ChitogenX stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange ChitogenX stocks are traded under the ticker CHNXF.
What is ChitogenX market cap?▼
Today ChitogenX has the market capitalization of 627,623.95
What is ChitogenX revenue for the last year?▼
ChitogenX revenue for the last year amounts to 0 USD.
What is ChitogenX net income for the last year?▼
CHNXF net income for the last year is -2.3M USD.
In which sector is ChitogenX located?▼
ChitogenX operates in the Health & Wellness sector.